开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-08-07 ms2911578317090476 来自河南省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-08-15 不懂科研的科研狗子

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：蛋白质组学
经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？

109 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-10-08 nihao_aiwenzhe

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：临床蛋白组学;蛋白组学;质谱
经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept

184 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-15 ms1000001868448704

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：蛋白组学
经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。

133 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-07-16 ms4000001156703951 来自河南省

Submitted to Journal状态5天了还没到编辑手里这个正常吗

93 0

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-03-31 ILVhera

审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况

305 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2017-09-18 LhtFantasy

想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!

540 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2017-10-04 奋斗党

是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表:
从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???

186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???

473 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-29 MS54455111222

一般期刊要求关键词有多少个？

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218957, encodeId=bf78221895e09, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2024.6.6 submitted to journal 2024.6.7 with editor 2024.6.15 under review 2024.7.19 required reviews completed 2024.7.26 minor review 2024.8.5 Revision submitted to journal 2024.8.6 under review 2024.8.6 required reviews completed 2024.8.7 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I8r04nfZNRXpu4gXibfNpjB3ibiaK7OU9H9tdMkACr0F5fkcq8Uf0kVqQjfS75Qx5b1xxUBzWH4yaVG1f2DDexicAA/132, createdBy=59a35228483, createdName=ms2911578317090476, createdTime=Wed Aug 07 17:00:10 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1238839, encodeId=790d123883913, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：蛋白质组学 经验分享：想请问大家的蛋白质组学结果后面都做基础实验验证了吗？没有验证有可能能接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211124/1e5cd5d4efd7465caf5bd5b725ef80a1/3ece342b14e94d08bab19d7ff6d8dadd.jpg, createdBy=a3015646862, createdName=不懂科研的科研狗子, createdTime=Mon Aug 15 17:39:09 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058677, encodeId=a63c10586e77e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床蛋白组学;蛋白组学;质谱 经验分享：2020-10-11 Submitted to Journal 2020-10-11 With Editor 2020-10-31 Under Review 2020-12-07 Decision in Process 2020-12-12 Minor Revision 2021-1-5 Revision Submitted to Journal 2021-1-16 Under Review 2021-4-21 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd045174283, createdName=nihao_aiwenzhe, createdTime=Fri Oct 08 18:04:23 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080465, encodeId=838b10804656c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：蛋白组学 经验分享：2021.09.10日投稿，09.21日外审，10.10日大修，11.03再次返稿，11.09再次外审，12.06审稿结束，12日接受。前后共花了3个月，挺快的。审稿人意见比较专业，需要深入分析蛋白组学结果。感谢贵贴，在我投稿期间给了我不少经验，希望好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0dc5555799, createdName=ms1000001868448704, createdTime=Wed Dec 15 22:49:34 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148299, encodeId=4de22148299a9, content=Submitted to Journal状态5天了还没到编辑手里这个正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Sun Jul 16 16:52:39 CST 2023, time=2023-07-16, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=587833, encodeId=e3e458e8331d, content=审稿慢得要死，以后别投这破杂志了，外审48天还没回来，写信问下什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Tue Mar 31 00:00:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547338, encodeId=d67354e33896, content=想请问.with editor三天后.直接decision in process.这个是什么情况啊?有知道的吗?是这个杂志外审前都要经历这个吗?请大神指教!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/25/7d591af3f5a10c3198529be94f1ae8f6.jpg, createdBy=59b11629228, createdName=LhtFantasy, createdTime=Mon Sep 18 14:40:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547918, encodeId=6bf254e918a4, content=是没有送审吗?最后什么情况?186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, beContent=186****3111(暂无匿称) 2016-05-17 15:42:00 发表: 从with editor 到 decision in process一个星期左右.中间都没有under review??是不是被拒的节奏啊各位大神???, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/17/e2d44e6cd5f4a914cc2f76efb1407351.jpg, createdBy=a1112051270, createdName=奋斗党, createdTime=Wed Oct 04 00:00:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102240, encodeId=58ce11022407e, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102239, encodeId=101e1102239b5, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 MS54455111222

关键词最少几个？

183 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务